These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
819 related items for PubMed ID: 18974645
1. Multicenter study to assess the in vitro activity of tigecycline by disk diffusion test against clinical isolates from Argentina. Fernández Canigia L, Kaufman S, Lanata L, Vay C, Giovanakis M, Bantar C, Argentinean Tigecycline Surveillance Group. Chemotherapy; 2009; 55(1):20-7. PubMed ID: 18974645 [Abstract] [Full Text] [Related]
2. Antimicrobial activity of tigecycline tested against nosocomial bacterial pathogens from patients hospitalized in the intensive care unit. Sader HS, Jones RN, Dowzicky MJ, Fritsche TR. Diagn Microbiol Infect Dis; 2005 Jul; 52(3):203-8. PubMed ID: 16105565 [Abstract] [Full Text] [Related]
5. Comparative in vitro activity of tigecycline and other antimicrobials against Gram-negative and Gram-positive organisms collected from the Asia-Pacific Rim as part of the Tigecycline Evaluation and Surveillance Trial (TEST). Bouchillon SK, Iredell JR, Barkham T, Lee K, Dowzicky MJ. Int J Antimicrob Agents; 2009 Feb; 33(2):130-6. PubMed ID: 18995992 [Abstract] [Full Text] [Related]
6. Potency and spectrum of tigecycline tested against an international collection of bacterial pathogens associated with skin and soft tissue infections (2000-2004). Fritsche TR, Sader HS, Stilwell MG, Dowzicky MJ, Jones RN. Diagn Microbiol Infect Dis; 2005 Jul; 52(3):195-201. PubMed ID: 16105564 [Abstract] [Full Text] [Related]
10. In vitro activity of tigecycline against 2423 clinical isolates and comparison of the available interpretation breakpoints. Papaparaskevas J, Tzouvelekis LS, Tsakris A, Pittaras TE, Legakis NJ, Hellenic Tigecycline Study Group. Diagn Microbiol Infect Dis; 2010 Feb; 66(2):187-94. PubMed ID: 19836184 [Abstract] [Full Text] [Related]
11. Susceptibility to tigecycline of isolates from samples collected in hospitalized patients with secondary peritonitis undergoing surgery. Tubau F, Liñares J, Rodríguez MD, Cercenado E, Aldea MJ, González-Romo F, Torroba L, Berdonces P, Plazas J, Aguilar L, Delgado A, García-Escribano N, Study Group. Diagn Microbiol Infect Dis; 2010 Mar; 66(3):308-13. PubMed ID: 20022193 [Abstract] [Full Text] [Related]
12. Antimicrobial activity of tigecycline against bacterial isolates from intensive care units in a teaching hospital in Central Saudi Arabia. Somily AM, Al-Khattaf AS, Kambal AM. Saudi Med J; 2010 Jan; 31(1):18-24. PubMed ID: 20062893 [Abstract] [Full Text] [Related]
19. A longitudinal analysis of antimicrobial susceptibility in clinical institutions in Germany as part of the Tigecycline Evaluation and Surveillance Trial (2004-2007). Seifert H, Dowzicky MJ. Chemotherapy; 2009 Jan; 55(4):241-52. PubMed ID: 19468222 [Abstract] [Full Text] [Related]
20. In vitro activity of tigecycline against resistant micro-organisms isolated from burn patients. Timurkaynak F, Arslan H, Azap OK, Senger SS, Başaran O, Karaman SO, Haberal M. Burns; 2008 Nov; 34(7):1033-6. PubMed ID: 18539397 [Abstract] [Full Text] [Related] Page: [Next] [New Search]